Akèy › Anplwayè › UCB BioSciences Inc.
UCB BioSciences Inc.: Salè H-1B ak pajon
UCB BioSciences Inc. depoze 18 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 18. Medyèn salè yo ofri a: $106,870.
Èske UCB BioSciences Inc. pajone visa H-1B?
UCB BioSciences Inc. depoze 18 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 3, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Scientist I | 3 | $86,549 |
| DMPK Lead | 2 | $200,300 |
| Scientist II | 2 | $114,007 |
| Head US Tox & GTx Tox Strategy Lead | 2 | $106,870 |
| Project Lead Statistician | 2 | $91,603 |
| Associate Scientist | 1 | $85,842 |
| Benefit Risk Excellence Lead | 1 | $138,800 |
| Senior Scientist II | 1 | $146,635 |
| Digital Transformation Lead Transvers. Delivery & US ES SPOC | 1 | $168,000 |
| Senior Scientist I Discovery Chemistry US | 1 | $147,576 |
| Senior Research Associate | 1 | $82,846 |
| Senior Scientist II Discovery Chemistry US | 1 | $122,450 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 2 | $86,549 |
| FY2024 | 3 | $200,300 |
| FY2025 | 6 | $142,718 |
| FY2026 | 7 | $106,870 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Molecular and Cellular Biologists6
- Medical Scientists, Except Epidemiologists5
- Biochemists and Biophysicists3
- Operations Research Analysts2
- Regulatory Affairs Specialists1
- Computer Systems Engineers/Architects1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Project Lead Statistician | $91,603 Nivo III | Morrisville, NC | Jun 3, 2026 | Oct 1, 2026 | Certifye |
| Head US Tox & GTx Tox Strategy Lead | $106,870 Nivo II | Cambridge, MA | Jun 1, 2026 | Oct 1, 2026 | Certifye |
| Senior Scientist II Discovery Chemistry US | $122,450 Nivo III | Cambridge, MA | May 21, 2026 | Oct 1, 2026 | Certifye |
| Project Lead Statistician | $91,603 Nivo III | Morrisville, NC | May 7, 2026 | Oct 1, 2026 | Certifye |
| Head US Tox & GTx Tox Strategy Lead | $106,870 Nivo II | Cambridge, MA | May 5, 2026 | Oct 1, 2026 | Certifye |
| Scientist II | $99,200–$130,200 Nivo II | Cambridge, MA | Apr 22, 2026 | Oct 1, 2026 | Certifye |
| Scientist II | $128,814 Nivo III | Cambridge, MA | Jan 6, 2026 | Jan 19, 2026 | Certifye |
| Digital Transformation Lead Transvers. Delivery & US ES SPOC | $168,000–$220,667 Nivo IV | Cambridge, MA | Jun 11, 2025 | Oct 1, 2025 | Certifye |
| Senior Scientist I Discovery Chemistry US | $147,576 Nivo IV | Cambridge, MA | Jun 3, 2025 | Oct 1, 2025 | Certifye |
| Senior Research Associate | $82,846 Nivo I | Cambridge, MA | May 23, 2025 | Oct 1, 2025 | Certifye |
| Benefit Risk Excellence Lead | $138,800–$231,300 Nivo IV | Raleigh, NC | Mar 5, 2025 | Aug 9, 2025 | Certifye |
| Senior Scientist II | $146,635 Nivo IV | Smyrna, GA | Feb 14, 2025 | Feb 14, 2025 | Certifye |
| Associate Scientist | $85,842–$105,500 Nivo II | Cambridge, MA | Oct 14, 2024 | Oct 14, 2024 | Certifye |
| Scientist I | $96,500–$126,600 Nivo II | Cambridge, MA | Aug 27, 2024 | Oct 1, 2024 | Certifye |
| DMPK Lead | $200,300–$262,900 Nivo IV | Cambridge, MA | Jun 6, 2024 | Oct 1, 2024 | Certifye |
| DMPK Lead | $200,300–$262,900 Nivo IV | Cambridge, MA | May 22, 2024 | Oct 1, 2024 | Certifye |
| Scientist I | $86,549–$96,549 Nivo II | Cambridge, MA | Jun 21, 2023 | Oct 1, 2023 | Certifye |
| Scientist I | $86,549–$96,549 Nivo II | Cambridge, MA | Jun 6, 2023 | Oct 1, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).